Correction: Overexpression of AKR1C3 significantly enhances human prostate cancer cells resistance to radiation

Oncotarget. 2020 Apr 28;11(17):1575. doi: 10.18632/oncotarget.27542.

¹ Department of Radiation Oncology, Peking University First Hospital, Peking University, Beijing, China.
² State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China.
³ Department of Radiation Oncology, Jiangsu Cancer Hospital Affiliated with Nanjing Medical University, Nanjing, China.
⁴ Tangshan People's Hospital, Hebei, China.
⁵ Beijing Reciproca Pharmaceutical Co. Ltd., Beijing, China.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.10347.].